All News
Is Trump’s new order a reprieve for biotech?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning.
Read MoreCanned Tuna Recall; Congressman Freezes During Floor Speech; Super Bowl 'Flu'?
(MedPage Today) -- Note that some links may require registration or subscription. Canned tuna that was sold at Costco, Trader Joe's, and H-E-B was recalled due to a risk of botulism.
Read MoreNew data on maternal mortality finds unexpected state trends
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Read MoreSTAT+: Apple launches sweeping new health study that may inform future features
Apple is launching a new study to investigate the relationships between different aspects of health that can be measured using its devices.
Read MoreNottingham NHS trust fined £1.6m over three newborn babies’ deaths
Adele O’Sullivan, Kahlani Rawson and Quinn Parker all died in 2021 in care of Nottingham university hospitals trustAn NHS trust has been fined £1.
Read MoreSTAT+: Tome founders launch next venture, an RNA contract research startup
Terrain Biosciences, backed by high-profile players in biotech, will design and supply RNA molecules for new therapies.
Read MoreEating from plastic takeout containers can increase heart failure risk – study
Study, adding to rising evidence of plastic-linked health risks, points to gut biome changes as a cause of heart failureSign up for our free Detox Your Kitchen newsletterEating from plastic takeout co
Read MoreFalcon ICU partners with Dr Mahajan Hospital to launch smart ICU unit in Mumbai
The new ICU unit is designed to meet the increasing demand of mid-size hospitals in Mumbai
Read MoreLifesigns secures strategic investment from Healthcare Capital
The investment aims to primarily advance Lifesigns’ AI and predictive algorithm capabilities, further enhancing its proprietary patient monitoring platform
Read More